West Pharmaceutical Services Inc
WST- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000105770
In the last 90 days, West Pharmaceutical Services Inc insiders filed 0 open-market purchases and 2 sales; 834 institutions reported holding it in 13F filings for Q2 2026, worth $25.2B in total; Gates Foundation Trust is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding West Pharmaceutical Services Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 698 | 4 | 735 | +41 |
| Shares | 69.5M | 14.3K | 68.1M | −1.34M (−1.9%) |
| Value | $24.0B | $4.95M | $26.0B | +$1.94B (+8.1%) |
4 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (92)
Institutions that held West Pharmaceutical Services Inc at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (51)
Institutions that held West Pharmaceutical Services Inc at the end of Q1 2023 and filed for Q2 2023 without it.
Not filed for Q2 2023 yet (4)
Institutions that held West Pharmaceutical Services Inc at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Security Asset Management | 11,669 | $4.04M |
| ETF Managers Group, LLC | 1,759 | $609.4K |
| Strata Wealth Advisors, LLC | 800 | $277.2K |
| Householder Group Estate & Retirement Specialist, LLC | 49 | $17.0K |